Dr Lyn Ferguson
- Clinical Lecturer in Chemical Pathology and Metabolic Medicine (Institute of Cardiovascular & Medical Sciences)
- Honorary Clinical Lecturer (School of Medicine, Dentistry & Nursing)
Lyn Ferguson trained in medicine at the University of Glasgow (MBChB Hons. 2010), with an intercalated BSc (MedSci) (first class Hons.) in Anatomy (2008). She undertook academic foundation and core medical training in the West of Scotland and obtained membership of the Royal College of Physicians and Surgeons of Glasgow (MRCP(Glasg)) in 2013, before commencing specialty training in Chemical Pathology and Metabolic Medicine in 2014. In 2016, she became a Diplomate member of the Royal College of Pathogists (DipRCPath).
From August 2016 to August 2019 she undertook a Clinical Research Fellowship, funded by the BHF Centre of Excellence at the University of Glasgow, and was co-investigator of the Immune Metabolic Associations in Psoriatic Arthritis (IMAPA) study. She was awarded her PhD in 2020, entitled 'Cardiometabolic comorbidities in psoriatic disease and modulation by phosphodiesterase (PDE) 4 inhibition'.
Currently she is a Clinical Lecturer in the Institute of Cardiovascular and Medical Sciences and is an Honorary Specialist Registrar in Clinical Biochemistry and Metabolic Medicine in the Queen Elizabeth University Hospital.
1 - Clinical Studies - IMAPA Study
Psoriasis and psoriatic arthritis are chronic inflammatory diseases of the skin and joints, which are also associated with increased risk of type 2 diabetes and cardiovascular disease. Obesity is a frequent comorbidity in psoriatic disease and is increasingly implicated in its pathogenesis, disease severity, and response to treatment. The medication apremilast, a phosphodiesterase (PDE)4 inhibitor, has been shown to improve psoriatic disease, as well as being associated with weight loss. The Immune Metabolic Associations in Psoriatic Arthritis (IMAPA) study aimed to evaluate the effects of PDE4 inhibition on metabolic, vascular, and immune status in psoriatic disease.
2 - Epidemiological studies - UK Biobank
In collaboration with colleagues from the Institute of Health and Wellbeing, research focuses on the causes, prevention, and management of diabetes, obesity, heart disease, and chronic rheumatic diseases using the UK Biobank. This is a prospective, population cohort study of 500,000 participants designed to determine lifestyle, environmental and genetic factors that predispose to adult chronic diseases.
Lyn Ferguson lectures on the MBChB year 2 curriculum.
Prizes, Awards and Distinctions
- 2017: Diabetes UK Professional Conference - Diabetes UK Type 2 Diabetes Research Award
- 2015: Association of Clinical Biochemistry - John King Award
- 2013: European Calcified Tissue Society (ECTS) - Anniversary Travel Grant
- 2008: University of Glasgow - Lorimer Bursary in Anatomy
- 2008: Glasgow Cardiovascular Research Centre - Wellcome Trust Vacation Scholarship